The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...
Product list 100 - 150:
| S.No | Compound Name | CAS | Remarks |
|---|---|---|---|
| 101 | (S)-5-Iodo-6-methoxy-α-methyl-2-naphthaleneacetic Acid | 116883-62-6 | Naproxen EP Impurity D |
| 102 | (αS)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid Methyl Este | 26159-35-3 | Naproxen EP Impurity E |
| 103 | (αS)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid Ethyl Ester | 31220-35-6 | |
| 104 | 2-Hydroxy-6-methoxynaphthalene | 5111-66-0 | Naproxen EP Impurity H |
| 105 | 6-Methoxy-2-naphthaleneacetic Acid | 23981-47-7 | Naproxen EP Impurity I (Desmethyl Naproxen) |
| 106 | 2-Methoxy-6-ethylnapthalene | 21388-17-0 | Naproxen EP Impurity J |
| 107 | 1-(6-Methoxynaphthalen-2-yl)ethanol | 77301-42-9 | Naproxen EP Impurity K |
| 108 | 2-Acetyl-6-methoxynaphthalene | 3900-45-6 | Naproxen EP Impurity L |
| 109 | 2-Methoxynaphthalene | 93-04-9 | Naproxen EP Impurity M |
| 110 | 2-Bromo-6-methoxynaphthalene | 5111-65-9 | Naproxen EP Impurity N |
| 111 | (R)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid | 23979-41-1 | Naproxen USP RC G |
| 112 | 6-Methoxy-2-naphthonitrile | 67886-70-8 | Naproxen Nitrile Impurity |
| 113 | 6-Methoxy-2-naphthoic Acid | 2471-70-7 | Naproxen EP Impurity O |
| 114 | (±)-2-(6-Methoxy-2-naphthyl)propionic Acid | 23981-80-8 | Naproxen racemate |
| 115 | 6-Hydroxy-2-naphthaleneacetic Acid | 10441-46-0 | Naproxen Impurity 1 |
| 116 | 6-Methoxy-α-methylene-2-naphthaleneacetic Acid | 27602-79-5 | Naproxen Dehydro Impurity(Under development) |
| 117 | α-(6-Methoxy-2-naphthyl)lactic Acid | 32721-11-2 | Alpha-Hydroxy Naproxen(Under development) |
| 118 | Carbocysteine sulphoxide | 5439-87-2 | Carbocysteine sulphoxide |
| 119 | Carbocysteine Lactum | 62305-89-9 | Carbocysteine Lactum |
| 120 | 4-(2-Aminophenyl)-3-morpholinone | 1082588-73-5 | 4-(2-Aminophenyl)-3-morpholinone |
| 121 | 4-(3-Aminophenyl)-3-morpholinone | 1082495-22-4 | 4-(3-Aminophenyl)-3-morpholinone |
| 122 | 4-(2-Nitrophenyl)morpholin-3-one | 845729-41-1 | 4-(2-Nitrophenyl)morpholin-3-one |
| 123 | R)-4-(Ethylamino)-3,4-dihydro-2-(3-hydroxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide | 186377-56-0 | Brinzolamide Impurity C |
| 124 | 4-(4-chlorophenyl)-1-(4-(dimethylamino)-4-oxo-3,3-diphenylbutyl)-4-hydroxypiperidine 1-oxide | 217471-03-9 | Loperamide N-Oxide |
| 125 | 2-Methyl-5-nitro-1-(2-oxiranylmethyl)-1H-imidazole | 16773-52-7 | Ornidazole epoxide |
| 126 | 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-methylethenyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid | 918972-54-0 | Montelukast EP Impurity B; Montelukast Methylstyrene |
| 127 | (R)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride | 156453-51-9 | Dapoxetine HCl [R-Isomer] |
| 128 | trans-4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol | 18683-95-9 | Ambroxol EP Impurity B |
| 129 | 6-Chloro-4-methoxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide | 2469039-23-2 | Lornoxicam Methyl Ether |
| 130 | 6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-,3-Pyridinecarboxylic Acid Methyl Ester | 1332579-70-0 | Methyl ester of Tazarotene |
| 131 | TAZAROTENE Carboxylic acid-sulfoxide | 603952-64-3 | TAZAROTENE Carboxylic acid-sulfoxide |
| 132 | 6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic Acid | 118292-41-4 | TAZAROTENE Carboxylic acid; Tazarotenic Acid |
| 133 | Levofloxacin Methyl Ester | 862690-19-5 | Levofloxacin Methyl Ester |
| 134 | (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid methyl ester | 177472-30-9 | Levofloxacin ethyl Ester |
| 135 | 5-Chloro-1-(4-piperidinyl)-2-benzimidazolidinone | 53786-28-0 | Domperidone EP Impurity A |
| 136 | 4-(6-Chloro-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)piperidine-1-carbaldehyde | 1346598-11-5 | Domperidone EP Impurity B |
| 137 | 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-1-oxido-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one | 118435-03-3 | Domperidone EP Impurity C; Domperidone N-Oxide |
| 138 | 5-Chloro-3-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one | 1614255-34-3 | Domperidone EP Impurity D |
| 139 | 1-[3-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propyl]-3-[3-(2-oxo-2,3-dihydro-1Hbenzimidazol-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one | 1346602-50-3 | Domperidone EP Impurity E |
| 140 | 1,3-bis[3-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propyl]-1,3-dihydro-2H-benzimidazol-2-one | 1391053-55-6 | Domperidone EP Impurity F |
| 141 | (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; sodium | 937370-10-0 | D-Pemetrexed Disodium,Pemetrexed EP Impurity E |
| 142 | 5-(Propylsulphanyl)-1H-benzimidazol-2-amine | 80983-36-4 | Albendazole EP Impurity A |
| 143 | Methyl N-[5-propylsulfinyl)-1H-benzo[d]imidazol-2-ylcarbamate | 54029-12-8 | Albendazole EP Impurity B |
| 144 | Methyl N-(5-propylsulfonyl)-1H-benzo[d]imidazol-2-ylcarbamate | 75184-71-3 | Albendazole EP Impurity C |
| 145 | 2-Amino-1H-benzimidazole-5-yl)propyl-sulfanedione | 80983-34-2 | Albendazole EP Impurity D |
| 146 | Methyl N(1H-benzo[d]imidazol-2-yl)carbamate | 10605-21-7 | Albendazole EP Impurity E |
| 147 | Methyl –N-5-(methylsulfanyl)-1H-benzo[d]imidazol-2-ylcarbamate | NA | Albendazole EP Impurity F |
| 148 | Methyl N 5-chloro-1H-benzo[d]imidazol-2-ylcarbamate | 20367-38-8 | Albendazole EP Impurity G |
| 149 | Methyl N 5-(2-methyl-4-oxopentan-2-yl)sulfanyl-1H-benzo[d]imidazol-2-ylcarbamate | 2469260-71-5 | Albendazole EP Impurity H(Under development) |
| 150 | Methy N (5-propoxy-1H-benzo[d]imidazol-2-ylcarbamate | 20559-55-1 | Albendazole EP Impurity I |
Suma Laboratories ® All rights reserved.